Liquid biopsy mutation panel for non-small cell lung cancer: analytical validation and clinical concordance.
Cancer genomics
Journal
NPJ precision oncology
ISSN: 2397-768X
Titre abrégé: NPJ Precis Oncol
Pays: England
ID NLM: 101708166
Informations de publication
Date de publication:
2020
2020
Historique:
received:
15
08
2019
accepted:
09
04
2020
entrez:
30
6
2020
pubmed:
1
7
2020
medline:
1
7
2020
Statut:
epublish
Résumé
Molecular testing for genomic variants is recommended in advanced non-small cell lung cancer (NSCLC). Standard tissue biopsy is sometimes infeasible, procedurally risky, or insufficient in tumor tissue quantity. We present the analytical validation and concordance study of
Identifiants
pubmed: 32596507
doi: 10.1038/s41698-020-0118-x
pii: 118
pmc: PMC7314769
doi:
Types de publication
Journal Article
Langues
eng
Pagination
15Investigateurs
Gregory Alexander
(G)
Frederick L Baehner
(FL)
Thomas Bauer
(T)
Anna Bergamaschi
(A)
John Crown
(J)
Deborah Davison
(D)
David A Eberhard
(DA)
Nashat Gabrail
(N)
James Han
(J)
William Irvin
(W)
Margarita Lopatin
(M)
James Orsini
(J)
Bradley T Sumrall
(BT)
Informations de copyright
© The Author(s) 2020.
Déclaration de conflit d'intérêts
Competing interestsL.S.S: Consultant for Inivata and Caris Life Sciences. H.H.: None. D.C.: None. S.C.: Received fees from Pfizer for working on their protocols. M.L.T.: None. D.I.: None. C.E.: Consultant fees from Merck Sharp & Dohme, Boehringer Ingelheim, and AstraZeneca; and lecture fees from Bristol-Myers Squibb and Pfizer. J.P.B.: Current employment at and stock ownership in Genomic Health, Inc. (now Exact Sciences Corp.). K.C.-L.: Current employment at and stock ownership in Genomic Health, Inc. (now Exact Sciences Corp.). C.S.: Previous employment at Genomic Health, Inc. (now Exact Sciences Corp.) during this work; consultant for Precision Medicine Asia Co Ltd and Cantargia AB. P.T.: None. G.A.: Previous employment at and stock ownership in Genomic Health, Inc. (now Exact Sciences Corp.). F.L.B.: Current employment at and stock ownership in Genomic Health, Inc. (now Exact Sciences Corp.). T.B.: None. A.B.: Previous employment at and stock ownership in Genomic Health, Inc. (now Exact Sciences Corp.). J.C.: Reports grants from Genomic Health, during the conduct of the study; personal fees from Genomic Health, outside the submitted work; and Genomic Health provided speakers for educational activities. D.D.: Previous employment at and stock ownership in Genomic Health, Inc. (now Exact Sciences Corp.). D.A.E.: Previous employment at and stock ownership in Genomic Health, Inc. (now Exact Sciences Corp.). N.G.: None. J.H.: Previous employment at and stock ownership in Genomic Health, Inc. (now Exact Sciences Corp.). W.I.,Jr.: None. M.L.: Previous employment at and stock ownership in Genomic Health, Inc. (now Exact Sciences Corp.). J.O.,Jr.: None. B.T.S: None.
Références
JAMA Oncol. 2015 May;1(2):149-57
pubmed: 26181014
Clin Chem. 2015 Sep;61(9):1191-6
pubmed: 26206882
N Engl J Med. 2012 Mar 8;366(10):883-892
pubmed: 22397650
BMC Cancer. 2016 Nov 8;16(1):864
pubmed: 27821131
Nat Med. 2014 May;20(5):548-54
pubmed: 24705333
Sci Transl Med. 2014 Feb 19;6(224):224ra24
pubmed: 24553385
Medicine (Baltimore). 2015 May;94(21):e775
pubmed: 26020382
Drugs. 2013 Sep;73(13):1503-15
pubmed: 23982599
Clin Cancer Res. 2015 Jun 1;21(11):2436-9
pubmed: 25754348
PLoS Med. 2005 Mar;2(3):e73
pubmed: 15737014
Oncologist. 2003;8(4):303-6
pubmed: 12897327
Medicine (Baltimore). 2015 Jul;94(29):e1216
pubmed: 26200646
J Thorac Oncol. 2014 Sep;9(9):1345-53
pubmed: 25122430
Oncologist. 2014 Oct;19(10):e5-11
pubmed: 25170012
Oncologist. 2018 Jun;23(6):740-745
pubmed: 29438093
BMC Cancer. 2014 Apr 28;14:294
pubmed: 24773774
N Engl J Med. 2014 Nov 20;371(21):1963-71
pubmed: 25264305
Lung Cancer. 2002 Jan;35(1):53-7
pubmed: 11750713
J Thorac Oncol. 2016 Oct;11(10):1682-9
pubmed: 27468938
Ann Oncol. 2017 Apr 1;28(4):784-790
pubmed: 28104619
Oncologist. 2014 Jul;19(7):774-9
pubmed: 24868098
Nat Med. 2015 Jun;21(6):560-2
pubmed: 25939061
J Thorac Oncol. 2015 Oct;10(10):1437-43
pubmed: 26295376
Nat Med. 2015 Jul;21(7):795-801
pubmed: 26030179
Lung Cancer. 2014 Jul;85(1):19-24
pubmed: 24768581
N Engl J Med. 2015 Apr 30;372(18):1689-99
pubmed: 25923549
N Engl J Med. 2018 Jan 11;378(2):113-125
pubmed: 29151359
J Thorac Oncol. 2015 Apr;10(4):603-10
pubmed: 25514801
Drugs. 2015 Jan;75(1):75-82
pubmed: 25428710
Ann Oncol. 2015 Jul;26(7):1415-21
pubmed: 25922063
J Clin Oncol. 2018 Jun 1;36(16):1631-1641
pubmed: 29504847
Rheumatology (Oxford). 2017 Feb;56(2):171-172
pubmed: 27694338
N Engl J Med. 2018 Feb 22;378(8):731-739
pubmed: 29466156
Ann Oncol. 2015 Sep;26(9):1883-1889
pubmed: 26105600
N Engl J Med. 2005 Feb 24;352(8):786-92
pubmed: 15728811
BMC Health Serv Res. 2017 Jan 17;17(1):45
pubmed: 28095840
Mol Oncol. 2015 Nov;9(9):1737-43
pubmed: 26071350
J Thorac Oncol. 2017 Oct;12(10):1503-1511
pubmed: 28751246
J Thorac Oncol. 2012 Jan;7(1):115-21
pubmed: 21900837
Science. 2014 Oct 10;346(6206):251-6
pubmed: 25301630
Clin Cancer Res. 2015 Jul 15;21(14):3196-203
pubmed: 25829397